DK0683780T3 - Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme - Google Patents

Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme

Info

Publication number
DK0683780T3
DK0683780T3 DK94906909T DK94906909T DK0683780T3 DK 0683780 T3 DK0683780 T3 DK 0683780T3 DK 94906909 T DK94906909 T DK 94906909T DK 94906909 T DK94906909 T DK 94906909T DK 0683780 T3 DK0683780 T3 DK 0683780T3
Authority
DK
Denmark
Prior art keywords
pct
imidazopyridines
treatment
gastrointestinal disorders
date aug
Prior art date
Application number
DK94906909T
Other languages
Danish (da)
English (en)
Inventor
Joerg Senn-Bilfinger
Gerhard Grundler
Georg Rainer
Stefan Postius
Richard Riedel
Wolfgang-Alexander Simon
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Application granted granted Critical
Publication of DK0683780T3 publication Critical patent/DK0683780T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK94906909T 1993-02-15 1994-02-07 Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme DK0683780T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH45393 1993-02-15
CH194593 1993-06-29
PCT/EP1994/000335 WO1994018199A1 (de) 1993-02-15 1994-02-07 Imidazopyridine und ihre anwendung zur behandlung von magen-darm krankheiten

Publications (1)

Publication Number Publication Date
DK0683780T3 true DK0683780T3 (da) 2000-09-25

Family

ID=25684624

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94906909T DK0683780T3 (da) 1993-02-15 1994-02-07 Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme

Country Status (29)

Country Link
US (1) US5665730A (no)
EP (1) EP0683780B1 (no)
JP (1) JP3447292B2 (no)
KR (1) KR100297057B1 (no)
CN (1) CN1052005C (no)
AT (1) ATE192151T1 (no)
AU (1) AU678434B2 (no)
BG (1) BG62773B1 (no)
CA (1) CA2156078C (no)
CZ (1) CZ287313B6 (no)
DE (1) DE59409312D1 (no)
DK (1) DK0683780T3 (no)
ES (1) ES2148317T3 (no)
FI (1) FI109537B (no)
GR (1) GR3033846T3 (no)
HU (1) HU219395B (no)
IL (1) IL108520A (no)
MY (1) MY111201A (no)
NO (1) NO304889B1 (no)
NZ (1) NZ261579A (no)
PL (1) PL175932B1 (no)
PT (1) PT683780E (no)
RO (1) RO117917B1 (no)
RU (1) RU2136682C1 (no)
SG (1) SG55184A1 (no)
SK (1) SK280822B6 (no)
TW (1) TW293008B (no)
UA (1) UA43841C2 (no)
WO (1) WO1994018199A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2191979A1 (en) * 1994-06-20 1995-12-28 Muneo Takatani Condensed imidazole compounds, their production and use
JPH10505331A (ja) * 1994-07-28 1998-05-26 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング ベンジルイミダゾピリジン
CZ22697A3 (en) * 1994-07-28 1997-07-16 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinone derivatives, process of their preparation and pharmaceutical composition containing thereof
AU3343295A (en) * 1994-08-12 1996-03-07 Byk Gulden Lomberg Chemische Fabrik Gmbh Imidazopyridine salt
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
JP2949474B2 (ja) * 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
DE19602855A1 (de) * 1996-01-26 1997-07-31 Byk Gulden Lomberg Chem Fab Neue 3-Methylimidazopyridine
AU1545297A (en) * 1996-01-26 1997-08-20 Byk Gulden Imidazopyridine halides
DE59712297D1 (de) * 1996-01-26 2005-06-09 Altana Pharma Ag 3-alkylimidazopyridine
WO1998042707A1 (en) * 1997-03-24 1998-10-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Tetrahydropyrido compounds
DE69823493T2 (de) 1997-03-24 2009-09-24 Nycomed Gmbh Tetrahydropyridoverbindungen
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
AU3966600A (en) * 1999-04-17 2000-11-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Haloalkoxy imidazonaphthyridines
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6780880B1 (en) * 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
CA2493618A1 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
AR043063A1 (es) * 2002-12-13 2005-07-13 Altana Pharma Ag Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
PL1606261T3 (pl) 2003-03-10 2010-04-30 Astrazeneca Ab Nowy sposób przygotowania roflumilastu
CN101361738A (zh) 2003-11-03 2009-02-11 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2-a]吡啶衍生物
AR049168A1 (es) * 2004-05-18 2006-07-05 Altana Pharma Ag Derivados de benzimidazol
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0204785A1 (de) * 1984-12-14 1986-12-17 Ulrich Möbius Halterung für skier
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
US4831041A (en) * 1986-11-26 1989-05-16 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound

Also Published As

Publication number Publication date
FI953838A0 (fi) 1995-08-14
MY111201A (en) 1999-09-30
PL175932B1 (pl) 1999-03-31
CA2156078A1 (en) 1994-08-18
RU2136682C1 (ru) 1999-09-10
AU678434B2 (en) 1997-05-29
FI109537B (fi) 2002-08-30
ATE192151T1 (de) 2000-05-15
NO304889B1 (no) 1999-03-01
PT683780E (pt) 2000-10-31
HU219395B (hu) 2001-04-28
SG55184A1 (en) 1998-12-21
KR960701051A (ko) 1996-02-24
BG99855A (bg) 1996-04-30
CN1119863A (zh) 1996-04-03
HUT72436A (en) 1996-04-29
WO1994018199A1 (de) 1994-08-18
US5665730A (en) 1997-09-09
TW293008B (no) 1996-12-11
JP3447292B2 (ja) 2003-09-16
NZ261579A (en) 1997-03-24
GR3033846T3 (en) 2000-10-31
AU6039194A (en) 1994-08-29
SK99795A3 (en) 1995-12-06
BG62773B1 (bg) 2000-07-31
SK280822B6 (sk) 2000-08-14
NO953187L (no) 1995-08-14
CZ287313B6 (en) 2000-10-11
FI953838A (fi) 1995-09-06
IL108520A0 (en) 1994-05-30
CA2156078C (en) 2005-02-01
RO117917B1 (ro) 2002-09-30
DE59409312D1 (de) 2000-05-31
NO953187D0 (no) 1995-08-14
KR100297057B1 (ko) 2001-10-24
JPH08506333A (ja) 1996-07-09
CZ208895A3 (en) 1995-12-13
PL310171A1 (en) 1995-11-27
CN1052005C (zh) 2000-05-03
IL108520A (en) 1997-09-30
EP0683780B1 (de) 2000-04-26
ES2148317T3 (es) 2000-10-16
EP0683780A1 (de) 1995-11-29
UA43841C2 (uk) 2002-01-15

Similar Documents

Publication Publication Date Title
DK0683780T3 (da) Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme
DK0790988T3 (da) Anvendelse af dioxomorpholiner til bekæmpelse af endoparasitter, nye dioxomorpholiner og fremgangsmåder til deres fremstilling
DK0723544T3 (da) Alkoxyalkylcarbamater af imidazo[1,2-a]pyridiner
DK0581959T3 (da) Anvendelse af makrolidforbindelser til øjensygdomme
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
FI943499A0 (fi) Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja
DK0678089T3 (da) N-Acylpyrrolidiner og lægemidler til behandling eller forebyggelse af cholecystokinin- og gastrin-relaterede forstyrrelser
DK0675895T3 (da) Etoposidderivater, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel og anvendelse deraf til fremstilling af et lægemiddel til anticancerbehandling
TW261613B (no)
ATE198887T1 (de) Substituierte arylthioalkylthiopyridine
DK0691846T3 (da) Imidazoquinoxalinoner til behandling af sygdomme i centralnervesystemet
NO952292L (no) Nye triazolokinazoliner, deres fremstilling og anvendelse